The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis

Journal of Biological Chemistry

Volumn 287, Issue 35, 2012, Pages 29406-29416

  Chan, Olivia ^a   Burke, J Daniel ^a   Gao, Darrin F ^a   Fish, Eleanor N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNE RESPONSE; CELLULAR FUNCTION; CHEMOKINES; DOSE-DEPENDENT MANNER; ENERGY DEMANDS; EX-VIVO; EXPERIMENTAL DATA; GLUCOSE UPTAKE; HUMAN CD3; T CELLS; UP-REGULATION;

ANTIBIOTICS; CELLS; CYTOLOGY; ENZYMES; GLUCOSE; NUTRIENTS; PATHOLOGY; SIGNALING;

BIOCHEMISTRY;

6 PHOSPHOFRUCTO 2 KINASE; ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; CD98 ANTIGEN; DEOXYGLUCOSE; GLUCOSE TRANSPORTER 1; GLYCOGEN SYNTHASE KINASE 3BETA; RANTES;

ARTICLE; CD3+ T LYMPHOCYTE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; LYMPHOCYTE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ACETYLTRANSFERASES; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; CELLS, CULTURED; CHEMOKINE CCL5; CHEMOTAXIS; FEMALE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; GLYCOLYSIS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; PHOSPHOFRUCTOKINASE-2; PYRAZOLES; PYRIMIDINES; RECEPTORS, CCR5; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84865479230     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.348946     Document Type: Article

References (62)

1. Mellado, M., Rodríguez-Frade, J. M., Mañes, S., and Martínez-A, C. (2001) Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol. 19, 397-421
2. Moser, B., Wolf, M., Walz, A., and Loetscher, P. (2004) Chemokines: Multiple levels of leukocyte migration control. Trends Immunol. 25, 75-84
3. Ward, S. G., Bacon, K., and Westwick, J. (1998) Chemokines and T lymphocytes: More than an attraction. Immunity 9, 1-11
4. Wong, M. M., and Fish, E. N. (2003) Chemokines: Attractive mediators of the immune response. Semin. Immunol. 15, 5-14
5. Balkwill, F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550
6. Luther, S. A., and Cyster, J. G. (2001) Chemokines as regulators of T cell differentiation. Nat. Immunol. 2, 102-107
7. Murooka, T. T., Rahbar, R., and Fish, E. N. (2009) CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation. Biochem. Biophys. Res. Commun. 387, 381-386
8. Murooka, T. T., Rahbar, R., Platanias, L. C., and Fish, E. N. (2008) CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1. Blood 111, 4892-4901
9. Murooka, T. T., Wong, M. M., Rahbar, R., Majchrzak-Kita, B., Proudfoot, A. E., and Fish, E. N. (2006) CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCL5 aggregation. J. Biol. Chem. 281, 25184-25194
10. Taub, D. D., Turcovski-Corrales, S. M., Key, M. L., Longo, D. L., and Murphy, W. J. (1996) Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156, 2095-2103
11. Turner, L., Ward, S. G., and Westwick, J. (1995) RANTES-activated human T lymphocytes. A role for phosphoinositide 3-kinase. J. Immunol. 155, 2437-2444
12. Appay, V., and Rowland-Jones, S. L. (2001) RANTES: A versatile and controversial chemokine. Trends Immunol. 22, 83-87
13. Duma, L., Häussinger, D., Rogowski, M., Lusso, P., and Grzesiek, S. (2007) Recognition of RANTES by extracellular parts of the CCR5 receptor. J. Mol. Biol. 365, 1063-1075
14. Juremalm, M., Olsson, N., and Nilsson, G. (2002) Selective CCL5/ RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem. Biophys. Res. Commun. 297, 480-485
15. Hay, N., and Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945
16. Edinger, A. L., and Thompson, C. B. (2002) Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13, 2276-2288
17. Laplante, M., and Sabatini, D. M. (2009) An emerging role of mTOR in lipid biosynthesis. Curr. Biol. 19, R1046-1052
18. Wullschleger, S., Loewith, R., and Hall, M. N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484
19. Wieman, H. L., Wofford, J. A., and Rathmell, J. C. (2007) Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol. Biol. Cell 18, 1437-1446
20. Rathmell, J. C., Elstrom, R. L., Cinalli, R. M., and Thompson, C. B. (2003) Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur. J. Immunol. 33, 2223-2232
21. Rathmell, J. C., Fox, C. J., Plas, D. R., Hammerman, P. S., Cinalli, R. M., and Thompson, C. B. (2003) Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol. Cell. Biol. 23, 7315-7328
22. Wofford, J. A., Wieman, H. L., Jacobs, S. R., Zhao, Y., and Rathmell, J. C. (2008) IL-7 promotes Glut1 trafficking and glucose uptake via STAT5- mediated activation of Akt to support T-cell survival. Blood 111, 2101-2111
23. Fujii, N., Jessen, N., and Goodyear, L. J. (2006) AMP-activated protein kinase and the regulation of glucose transport. Am. J. Physiol. Endocrinol. Metab. 291, E867-877
24. Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., and Shaw, R. J. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226
25. Kimura, N., Tokunaga, C., Dalal, S., Richardson, C., Yoshino, K., Hara, K., Kemp, B. E., Witters, L. A., Mimura, O., and Yonezawa, K. (2003) A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8, 65-79
26. Shaw, R. J. (2009) LKB1 and AMP-activated protein kinase control of mTOR signaling and growth. Acta Physiol. 196, 65-80
27. Buzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., and Thompson, C. B. (2007) Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 67, 6745-6752
28. Marsin, A. S., Bertrand, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent, M. F., Van den Berghe, G., Carling, D., and Hue, L. (2000) Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10, 1247-1255
29. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., and Moller, D. E. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174
30. Doble, B. W., and Woodgett, J. R. (2003) GSK-3: Tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186
31. Graham, J. R., Tullai, J. W., and Cooper, G. M. (2010) GSK-3 represses growth factor-inducible genes by inhibiting NF-κB in quiescent cells. The Journal of biological chemistry 285, 4472-4480
32. Jope, R. S., and Johnson, G. V. (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102
33. Carling, D. (2004) The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem. Sci. 29, 18-24
34. Hardie, D. G., Carling, D., and Carlson, M. (1998) The AMP-activated/ SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67, 821-855
35. Hayashi, T., Hirshman, M. F., Fujii, N., Habinowski, S. A., Witters, L. A., and Goodyear, L. J. (2000) Metabolic stress and altered glucose transport: Activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49, 527-531
36. Hardie, D. G. (2004) AMP-activated protein kinase: A master switch in glucose and lipid metabolism. Rev. Endocr. Metab. Disord. 5, 119-125
37. Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., and Thompson, C. B. (2002) The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769-777
38. Maciver, N. J., Jacobs, S. R., Wieman, H. L., Wofford, J. A., Coloff, J. L., and Rathmell, J. C. (2008) Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukoc. Biol. 84, 949-957
39. Bentley, J., Itchayanan, D., Barnes, K., McIntosh, E., Tang, X., Downes, C. P., Holman, G. D., Whetton, A. D., Owen-Lynch, P. J., and Baldwin, S. A. (2003) Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface. J. Biol. Chem. 278, 39337-39348
40. Devés, R., and Boyd, C. A. (2000) Surface antigen CD98(4F2): Not a single membrane protein, but a family of proteins with multiple functions. J. Membr. Biol. 173, 165-177
41. Ley, K., Laudanna, C., Cybulsky, M. I., and Nourshargh, S. (2007) Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689
42. Cyster, J. G. (1999) Chemokines and cell migration in secondary lymphoid organs. Science 286, 2098-2102
43. Nieto, M., Frade, J. M., Sancho, D., Mellado, M., Martinez-A, C., and Sánchez-Madrid, F. (1997) Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis. J. Exp. Med. 186, 153-158
44. Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y., Gao, B., Wierzbicki, M., Verbeuren, T. J., Shaw, R. J., Cohen, R. A., and Zang, M. (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376-388
45. Brownsey, R. W., Boone, A. N., Elliott, J. E., Kulpa, J. E., and Lee, W. M. (2006) Regulation of acetyl-CoA carboxylase. Biochem. Soc. Trans. 34, 223-227
46. Plas, D. R., Talapatra, S., Edinger, A. L., Rathmell, J. C., and Thompson, C. B. (2001) Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. The Journal of biological chemistry 276, 12041-12048
47. Calder, P. C., Dimitriadis, G., and Newsholme, P. (2007) Glucose metabolism in lymphoid and inflammatory cells and tissues. Curr. Opin. Clin. Nutr. Metab. Care 10, 531-540
48. Fox, C. J., Hammerman, P. S., and Thompson, C. B. (2005) Fuel feeds function: Energy metabolism and the T-cell response. Nat. Rev. Immunol. 5, 844-852
49. Frauwirth, K. A., and Thompson, C. B. (2004) Regulation of T lymphocyte metabolism. J. Immunol. 172, 4661-4665
50. Kahn, B. B., Rossetti, L., Lodish, H. F., and Charron, M. J. (1991) Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J. Clin. Invest. 87, 2197-2206
51. Somwar, R., Koterski, S., Sweeney, G., Sciotti, R., Djuric, S., Berg, C., Trevillyan, J., Scherer, P. E., Rondinone, C. M., and Klip, A. (2002) A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation. J. Biol. Chem. 277, 50386-50395
52. Sweeney, G., Keen, J., Somwar, R., Konrad, D., Garg, R., and Klip, A. (2001) High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells. Endocrinology 142, 4806-4812
53. Buller, C. L., Loberg, R. D., Fan, M. H., Zhu, Q., Park, J. L., Vesely, E., Inoki, K., Guan, K. L., and Brosius, F. C., 3rd. (2008) A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am. J. Physiol. Cell Physiol. 295, C836-843
54. Carr, E. L., Kelman, A., Wu, G. S., Gopaul, R., Senkevitch, E., Aghvanyan, A., Turay, A. M., and Frauwirth, K. A. (2010) Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J. Immunol. 185, 1037-1044
55. Finlay, D., and Cantrell, D. (2010) Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration. Ann. N.Y. Acad. Sci. 1183, 149-157
56. Aft, R. L., Zhang, F. W., and Gius, D. (2002) Evaluation of 2-deoxy-Dglucose as a chemotherapeutic agent: Mechanism of cell death. Br. J. Cancer 87, 805-812
57. Greiner, E. F., Guppy, M., and Brand, K. (1994) Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J. Biol. Chem. 269, 31484-31490
58. Beckner, M. E., Stracke, M. L., Liotta, L. A., and Schiffmann, E. (1990) Glycolysis as primary energy source in tumor cell chemotaxis. J. Natl. Cancer Inst. 82, 1836-1840
59. Kroemer, G., and Pouyssegur, J. (2008) Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell 13, 472-482
60. Nakano, A., Kato, H., Watanabe, T., Min, K. D., Yamazaki, S., Asano, Y., Seguchi, O., Higo, S., Shintani, Y., Asanuma, H., Asakura, M., Minamino, T., Kaibuchi, K., Mochizuki, N., Kitakaze, M., and Takashima, S. (2010) AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nat. Cell Biol. 12, 583-590
61. Williams, T., and Brenman, J. E. (2008) LKB1 and AMPK in cell polarity and division. Trends Cell Biol. 18, 193-198
62. Miranda, L., Carpentier, S., Platek, A., Hussain, N., Gueuning, M. A., Vertommen, D., Ozkan, Y., Sid, B., Hue, L., Courtoy, P. J., Rider, M. H., and Horman, S. (2010) AMP-activated protein kinase induces actin cytoskeleton reorganization in epithelial cells. Biochem. Biophys. Res. Commun. 396, 656-661